Summary
In previous studies concerning the sympathetic outflow during converting enzyme inhibition, no significant changes after chronic treatment could be observed. Therefore, we investigated the effects of the long-acting converting enzyme inhibitor ramipril on the neuronal and extraneuronal uptake of SHR. Ramipril was administered either i.v. or orally to SHR, whereas desipramine or corticosterone were additionally infused to block the neuronal or extraneuronal uptake of catecholamines. As an index of sympathetic outflow, plasma noradrenaline and adrenaline concentrations were determined during preganglionic stimulation of the spinal cord using HPLC and ELCD. Blood pressure of SHR was measured in a carotid artery and was significantly decreased in the ramipril treated group under resting and stimulating conditions. Ramipril did not influence stimulated sympathetic outflow. However, in acute and chronic experiments ramipril led to an additive effect to desipramine concerning stimulated circulating catecholamines. Similar results could be obtained after blocking the uptake-2 with corticosterone. 3H-NA-uptake into the hearts of SHR was significantly diminished by about 10% after chronic ramipril administration. It is suggested that ramipril is able to decrease the neuronal and extraneuronal uptake of catecholamines by an unspecific effect due to the comparably high lipophilicity. The blood pressure lowering effect of ramipril is not supported by an inhibition of presynaptic noradrenaline release.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Berecek KH, Kirk KA, Nagahama S, Oparil S (1987) Sympathetic function in spontaneously hypertensive rats after chronic administration of captopril. Am J Physiol 252: H796 — H806
Dominiak P, Elfrath A, Türck D (1987) Effects of chronic treatment with ramipril, a new ACE blocking agent, on presynaptic sympathetic nervous system of SHR. Clin Exp Hypertens ATheor 9: 369–373
Dominiak P, Elfrath A, Türck D (1987) Biosynthesis of catecholamines and sympathetic outflow in spontaneously hypertensive rats (SHR) after chronic treatment with CE-blocking agents. J Cardiovasc Pharmacol 10 (Supp17): S122–5124
Erikson BM, Persson BA (1982) Determination of catecholamines in rat heart tissue and plasma samples by liquid chromatography with electrochemical detection. J Chromatogr 228: 143–154
Gillespie JS, Muir TC (1967) A method of stimulating the complete sympathetic outflow from the spinal cord to blood vessels in the pithed rat. Br J Pharmac Chemother 30: 78–87
Gohlke P, Urbach H, Schölkens B, Unger Th (1989) Inhibition of converting enzyme in the cerebrospinal fluid of rats after oral treatment with converting enzyme inhibitors. J Pharmacol Exp Ther 249: 609–616
Grohmann M, Trendelenburg U (1988) The handling of five amines by the extraneuronal deaminating system of the rat heart. Naunyn-Schmiedeberg’s Arch Pharmacol 337: 159–163
Majewski H, Hedler L, Schurr C, Starke K (1984) Modulation of noradrenaline release in the pithed rabbit: a role for angiotensin II. J Cardiovasc Pharmacol 6: 888–896
Maxwell RA, Keenan DP, Chaplin E, Roth B, Eckhardt SB (1969) Molecular features affecting the potency of tricyclic antidepressants and structurally related compounds as inhibitors of the uptake of tritiated norepinephrine by rabbit aortic strips. J Pharmacol Exp Ther 66: 320–329
Peach MJ (1977) Renin-angiotensin system: biochemistry and mechanism of action. Physiol Rev 57: 313–370
Schömig E, Michael-Hepp J, Bönisch H (1988) Inhibition of neuronal adrenaline uptake (uptakes) and desepramine binding by N-ethylmaleimide ( NEM ). Naunyn-Schmiedeberg’s Arch Pharmacol 337: 633–636
Starke K, Taube HD, Borowski E (1977) Presynaptic receptor systems in catecholaminergic transmission. Biochem Pharmacol 26: 259–268
Trendelenburg U (1980) A kinetic analysis of the extraneuronal uptake and metabolism of catecholamines. Rev Physiol Biochem Pharmacol 87:33 ff
Trendelenburg U (1986) The metabolizing systems involved in the inactivation of catecholamines. Naunyn-Schmiedeberg’s Arch Pharmacol 332: 201–207
Wenting GJ, Manin’t Veld AJ, Woitliez AJ, Derk FHM, Schalekamp MADH (1984) Captopril in treatment of severe acute and chronic heart failure. Progress in Pharmacology, 5/3: 107–112, Fischer Verlag, Stuttgart
Xiang J-Z, Linz W, Becker H, Ganten D, Lang RE, Schölkens B, Unger Th (1985) Effects of converting enzyme inhibitors: ramipril and enalapril on peptide action and sympathetic neurotransmission in the isolated heart. Eur J Pharmacol 113: 215–223
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Dominiak, P., Blöchl, A. (1991). Does converting enzyme inhibition change the neuronal and extraneuronal uptake of catecholamines?. In: Gülch, R.W., Kissling, G. (eds) Current Topics in Heart Failure. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-662-30769-4_14
Download citation
DOI: https://doi.org/10.1007/978-3-662-30769-4_14
Publisher Name: Steinkopff, Heidelberg
Print ISBN: 978-3-7985-0894-1
Online ISBN: 978-3-662-30769-4
eBook Packages: Springer Book Archive